Impact of neonatal morbidity on the risk of developmental delay in late preterm infants

Sílvia Martínez-Nadal1, Xavier Demestre1, Luisa Schonhaut2

  • 1Department of Pediatrics, Hospital de Barcelona-SCIAS, Barcelona, Spain.

Early Human Development
|November 15, 2017
PubMed

Insights

Complicated late preterm infants (cLPI) show higher risks for developmental delay (DD) in communication at age 4, particularly with respiratory issues. Caesarean delivery is a key perinatal risk factor for DD.

Area of Science:

  • Neonatal development
  • Pediatric neurology
  • Developmental pediatrics

Background:

  • Late preterm infants (LPI) face increased risks of developmental delay (DD) compared to term-born infants.
  • The specific links between perinatal complications and DD in LPI require further clarification.

Purpose of the Study:

  • To compare DD risk at age 4 between complicated LPI (cLPI), uncomplicated LPI (uLPI), and term-born infants.
  • To identify maternal and perinatal factors associated with DD risk.
  • To analyze the association between perinatal morbidity and DD risk in LPI.

Main Methods:

  • Retrospective cohort study of 163 LPI (47 cLPI, 116 uLPI) and 158 term infants.
  • Developmental delay assessed using the Ages & Stages Questionnaires® 3rd Spanish version (ASQ3).
  • Multivariate logistic regression analyzed associations between DD risk and maternal/perinatal factors.

Main Results:

  • cLPI exhibited a higher risk of DD in the communication domain compared to term infants.
  • Respiratory pathology in cLPI was linked to increased communication domain DD.
  • Caesarean delivery emerged as the sole maternal perinatal risk factor for DD, particularly affecting gross motor development.

Conclusions:

  • At 4 years, cLPI, especially those with respiratory morbidity, face a higher risk of communication delay.
  • Caesarean delivery is identified as the primary perinatal risk factor for DD in this cohort.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
46.5K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K